Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
The Journal of Infection|August 31, 2024
Children with hemoglobin C or S trait have low serologic responses to a subset of malaria variant surface antigensRachel D Bailey, Jonathan G Lawton, Amadou Niangaly, et al.
Msphere|October 4, 2023
Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1sMadison A Tewey, Drissa Coulibaly, Jonathan G Lawton, et al.
Msphere|March 22, 2019
Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria ExposureAlbert E Zhou, Andrea A Berry, Jason A Bailey, et al.
Science Translational Medicine|December 8, 2022
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malariaSodiomon B Sirima, Alphonse Ouédraogo, Alfred B Tiono, et al.
Nature Communications|May 18, 2025
A shared inflammatory signature across severe malaria syndromes manifested by transcriptomic, proteomic and metabolomic analysesRafal S Sobota, Emily M Stucke, Drissa Coulibaly, et al.
Plos One|January 24, 2008
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
Plos One|February 9, 2010
Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
The New England Journal of Medicine|September 16, 2011
A field trial to assess a blood-stage malaria vaccineMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
Genome Medicine|January 10, 2020
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potentialKara A Moser, Elliott F Drábek, Ankit Dwivedi, et al.
Plos One|November 22, 2013
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trialMatthew B Laurens, Mahamadou A Thera, Drissa Coulibaly, et al.
Pageof 18